Literature DB >> 10364915

Serum samples of patients with rheumatoid arthritis contain a specific autoantibody to "denatured" aldolase A in the osteoblast-like cell line, MG-63.

F Ukaji1, I Kitajima, T Kubo, C Shimizu, T Nakajima, I Maruyama.   

Abstract

OBJECTIVE: To identify rheumatoid arthritis (RA) specific autoantibody and its antigen in the human osteoblast-like cell line, MG-63.
METHODS: MG-63 cell extract was subjected to western blotting by using RA and normal serum samples as probes. The autoantigen was purified and its N-terminal sequence was determined by automated Edman degradation. The reactivity of denatured aldolase A was evaluated by immunoblotting. Screening by enzyme linked immunosorbent assay (ELISA) using the autoantibody was performed.
RESULTS: 40 kDa protein was found only in the RA serum samples and it was identified as aldolase A. A polyclonal antibody for rabbit muscle aldolase A bound to the 40 kDa protein and reacted in preference with the denatured enzyme. Using ELISA for denatured rabbit aldolase A, the autoantibody was found in approximately 10% of RA patients, whereas it was not found in the other arthropathy and healthy adults.
CONCLUSION: This 40 kDa anti-aldolase A autoantibody, which was identified only in serum samples of RA patients with severe bone erosion, could be related to a certain event that induces RA specific joint destructions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364915      PMCID: PMC1752850          DOI: 10.1136/ard.58.3.169

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  18 in total

1.  The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis.

Authors:  M Simon; E Girbal; M Sebbag; V Gomès-Daudrix; C Vincent; G Salama; G Serre
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

2.  Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films.

Authors:  A Larsen; K Dale; M Eek
Journal:  Acta Radiol Diagn (Stockh)       Date:  1977-07

3.  Binding of monomeric and aggregated immunoglobulin to enzymes. A source of artefact in antibody assays.

Authors:  B P O'Hara; J Pyle; D McCarthy; J R Archer
Journal:  J Immunol Methods       Date:  1989-01-17       Impact factor: 2.303

4.  Clinical significance of antibodies to native or denatured 60-kd or 52-kd Ro/SS-A proteins in Sjögren's syndrome.

Authors:  K Tsuzaka; T Fujii; M Akizuki; T Mimori; T Tojo; H Fujii; Y Tsukatani; A Kubo; M Homma
Journal:  Arthritis Rheum       Date:  1994-01

5.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

6.  Specificity of antibodies to type II collagen in rheumatoid arthritis.

Authors:  K Terato; Y Shimozuru; K Katayama; Y Takemitsu; I Yamashita; M Miyatsu; K Fujii; M Sagara; S Kobayashi; M Goto
Journal:  Arthritis Rheum       Date:  1990-10

7.  Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex.

Authors:  G Steiner; K Hartmuth; K Skriner; I Maurer-Fogy; A Sinski; E Thalmann; W Hassfeld; A Barta; J S Smolen
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

8.  Autoantibodies to the Ro/SSA antigen are conformation dependent. I: Anti-60 kD antibodies are mainly directed to the native protein; anti-52 kD antibodies are mainly directed to the denatured protein.

Authors:  Y Itoh; M Reichlin
Journal:  Autoimmunity       Date:  1992       Impact factor: 2.815

9.  Incidence and specificity of antibodies to types I, II, III, IV, and V collagen in rheumatoid arthritis and other rheumatic diseases as measured by 125I-radioimmunoassay.

Authors:  J M Stuart; E H Huffstutter; A S Townes; A H Kang
Journal:  Arthritis Rheum       Date:  1983-07

10.  Autoantibody to the nuclear antigen RA33: a marker for early rheumatoid arthritis.

Authors:  W Hassfeld; G Steiner; W Graninger; G Witzmann; H Schweitzer; J S Smolen
Journal:  Br J Rheumatol       Date:  1993-03
View more
  14 in total

1.  Proteomic identification of aldolase A as an autoantibody target in patients with atypical movement disorders.

Authors:  Daniela Privitera; Valeria Corti; Massimo Alessio; Maria Antonietta Volontè; Antonietta Volontè; Vito Lampasona; Giancarlo Comi; Gianvito Martino; Diego Franciotta; Roberto Furlan; Raffaella Fazio
Journal:  Neurol Sci       Date:  2012-03-06       Impact factor: 3.307

Review 2.  Nutrition and fasting mimicking diets in the prevention and treatment of autoimmune diseases and immunosenescence.

Authors:  In Young Choi; Changhan Lee; Valter D Longo
Journal:  Mol Cell Endocrinol       Date:  2017-01-28       Impact factor: 4.102

3.  Onchocerca volvulus glycolytic enzyme fructose-1,6-bisphosphate aldolase as a target for a protective immune response in humans.

Authors:  James S McCarthy; Moira Wieseman; Joe Tropea; David Kaslow; David Abraham; Sara Lustigman; Rocky Tuan; Ronald H Guderian; Thomas B Nutman
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

4.  Melanoma-associated retinopathy: a paraneoplastic autoimmune complication.

Authors:  Ying Lu; Lin Jia; Shirley He; Mary C Hurley; Monique J Leys; Thiran Jayasundera; John R Heckenlively
Journal:  Arch Ophthalmol       Date:  2009-12

5.  Accumulation of citrullinated proteins by up-regulated peptidylarginine deiminase 2 in brains of scrapie-infected mice: a possible role in pathogenesis.

Authors:  Byungki Jang; Eunah Kim; Jin-Kyu Choi; Jae-Kwang Jin; Jae-Il Kim; Akihito Ishigami; Naoki Maruyama; Richard I Carp; Yong-Sun Kim; Eun-Kyoung Choi
Journal:  Am J Pathol       Date:  2008-09-11       Impact factor: 4.307

Review 6.  Redox-Mediated Carbamylation As a Hapten Model Applied to the Origin of Antibodies to Modified Proteins in Rheumatoid Arthritis.

Authors:  Maria Isabel Trejo-Zambrano; Eduardo Gómez-Bañuelos; Felipe Andrade
Journal:  Antioxid Redox Signal       Date:  2021-06-04       Impact factor: 7.468

7.  Differential proteomic analysis of synovial fluid from rheumatoid arthritis and osteoarthritis patients.

Authors:  Lavanya Balakrishnan; Mitali Bhattacharjee; Sartaj Ahmad; Raja Sekhar Nirujogi; Santosh Renuse; Yashwanth Subbannayya; Arivusudar Marimuthu; Srinivas M Srikanth; Rajesh Raju; Mukesh Dhillon; Navjyot Kaur; Ramesh Jois; Vivek Vasudev; Yl Ramachandra; Nandini A Sahasrabuddhe; Ts Keshava Prasad; Sujatha Mohan; Harsha Gowda; Subramanian Shankar; Akhilesh Pandey
Journal:  Clin Proteomics       Date:  2014-01-06       Impact factor: 3.988

Review 8.  T-cell metabolism in autoimmune disease.

Authors:  Zhen Yang; Eric L Matteson; Jörg J Goronzy; Cornelia M Weyand
Journal:  Arthritis Res Ther       Date:  2015-02-11       Impact factor: 5.156

Review 9.  Impact of Autoantibodies against Glycolytic Enzymes on Pathogenicity of Autoimmune Retinopathy and Other Autoimmune Disorders.

Authors:  Grazyna Adamus
Journal:  Front Immunol       Date:  2017-04-28       Impact factor: 7.561

10.  Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes.

Authors:  Vincent Goëb; Marlène Thomas-L'Otellier; Romain Daveau; Roland Charlionet; Patrice Fardellone; Xavier Le Loët; François Tron; Danièle Gilbert; Olivier Vittecoq
Journal:  Arthritis Res Ther       Date:  2009-03-10       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.